CD4(+)CD25(+) T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion

por Herman, Ann E., Freeman, Gordon J., Mathis, Diane, Benoist, Christophe
Publicado 2004

Identification of an IL-22-Dependent Gene Signature as a Pharmacodynamic Biomarker

por Rae, Julie, Hackney, Jason, Huang, Kevin, Keir, Mary, Herman, Ann
Publicado 2021

Where CD4(+)CD25(+) T reg cells impinge on autoimmune diabetes

por Chen, Zhibin, Herman, Ann E., Matos, Michael, Mathis, Diane, Benoist, Christophe
Publicado 2005

Inhibition of c-Kit Is Not Required for Reversal of Hyperglycemia by Imatinib in NOD Mice

por Lau, Janet, Zhou, Qiang, Sutton, Susan E., Herman, Ann E., Schmedt, Christian, Glynne, Richard
Publicado 2014

Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO

por Gibiansky, Ekaterina, Petry, Claire, Mercier, Francois, Günther, Andreas, Herman, Ann, Kappos, Ludwig, Hauser, Stephen, Yamamoto, Yumi, Wang, Qing, Model, Fabian, Kletzl, Heidemarie
Publicado 2020

Development of an age‐adjusted model for blood neurofilament light chain

por Harp, Christopher, Thanei, Gian‐Andrea, Jia, Xiaoming, Kuhle, Jens, Leppert, David, Schaedelin, Sabine, Benkert, Pascal, von Büdingen, H‐Christian, Hendricks, Robert, Herman, Ann
Publicado 2022

IL-2 Immunotherapy Reveals Potential for Innate Beta Cell Regeneration in the Non-Obese Diabetic Mouse Model of Autoimmune Diabetes

por Diaz-de-Durana, Yaiza, Lau, Janet, Knee, Deborah, Filippi, Christophe, Londei, Marco, McNamara, Peter, Nasoff, Marc, DiDonato, Michael, Glynne, Richard, Herman, Ann E.
Publicado 2013

Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)

por Kennedy, William P, Simon, J Abraham, Offutt, Carolyn, Horn, Priscilla, Herman, Ann, Townsend, Michael J, Tang, Meina T, Grogan, Jane L, Hsieh, Frank, Davis, John C
Publicado 2014

Nonclinical safety assessment of a human interleukin‐22FC IG fusion protein demonstrates in vitro to in vivo and cross‐species translatability

por Lee, Donna W., Zhong, Shelly, Pai, Rama, Rae, Julie, Sukumaran, Siddharth, Stefanich, Eric G., Lutman, Jeff, Doudement, Estelle, Wang, Xiaoting, Harder, Brandon, Lekkerkerker, Annemarie, Herman, Ann, Ouyang, Wenjun, Danilenko, Dimitry M.
Publicado 2018

Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials

por Loomis, Stephanie J., Sadhu, Nilanjana, Fisher, Elizabeth, Gafson, Arie R., Huang, Yunfeng, Yang, Chengran, Hughes, Emily E., Marshall, Eric, Herman, Ann, John, Sally, Runz, Heiko, Jia, Xiaoming, Bhangale, Tushar, Bronson, Paola G.
Publicado 2023

Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial

por Laurent, Sarah A., Strauli, Nicolas B., Eggers, Erica L., Wu, Hao, Michel, Brady, Demuth, Stanislas, Palanichamy, Arumugam, Wilson, Michael R., Sirota, Marina, Hernandez, Ryan D., Cree, Bruce Anthony Campbell, Herman, Ann E., von Büdingen, H.-Christian
Publicado 2023

Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizuma...

por Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, Kuhle, Jens, Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, Herman, Ann E.
Publicado 2023

Inhibition of DYRK1A and GSK3B induces human β-cell proliferation

por Shen, Weijun, Taylor, Brandon, Jin, Qihui, Nguyen-Tran, Van, Meeusen, Shelly, Zhang, You-Qing, Kamireddy, Anwesh, Swafford, Austin, Powers, Andrew F., Walker, John, Lamb, John, Bursalaya, Badry, DiDonato, Michael, Harb, George, Qiu, Minhua, Filippi, Christophe M., Deaton, Lisa, Turk, Carolina N., Suarez-Pinzon, Wilma L., Liu, Yahu, Hao, Xueshi, Mo, Tingting, Yan, Shanshan, Li, Jing, Herman, Ann E., Hering, Bernhard J., Wu, Tom, Martin Seidel, H., McNamara, Peter, Glynne, Richard, Laffitte, Bryan
Publicado 2015

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

por Shinoda, Koji, Li, Rui, Rezk, Ayman, Mexhitaj, Ina, Patterson, Kristina R., Kakara, Mihir, Zuroff, Leah, Bennett, Jeffrey L., von Büdingen, H.-Christian, Carruthers, Robert, Edwards, Keith R., Fallis, Robert, Giacomini, Paul S., Greenberg, Benjamin M., Hafler, David A., Ionete, Carolina, Kaunzner, Ulrike W., Lock, Christopher B., Longbrake, Erin E., Pardo, Gabriel, Piehl, Fredrik, Weber, Martin S., Ziemssen, Tjalf, Jacobs, Dina, Gelfand, Jeffrey M., Cross, Anne H., Cameron, Briana, Musch, Bruno, Winger, Ryan C., Jia, Xiaoming, Harp, Christopher T., Herman, Ann, Bar-Or, Amit
Publicado 2023